Pancreatic Neoplasms

"Pancreatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Descriptor ID	D010190
MeSH Number(s)	C04.588.274.761 C04.588.322.475 C06.301.761 C06.689.667 C19.344.421
Concept/Terms	Pancreatic Neoplasms Pancreatic Neoplasms Neoplasm, Pancreatic Pancreatic Neoplasm Pancreas Neoplasms Neoplasm, Pancreas Neoplasms, Pancreas Pancreas Neoplasm Neoplasms, Pancreatic Cancer of Pancreas Cancer of Pancreas Pancreas Cancers Pancreas Cancer Cancer, Pancreas Cancers, Pancreas Pancreatic Cancer Cancer, Pancreatic Cancers, Pancreatic Pancreatic Cancers Cancer of the Pancreas

Below are MeSH descriptors whose meaning is more general than "Pancreatic Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Digestive System Neoplasms [C04.588.274]
Pancreatic Neoplasms [C04.588.274.761]
Endocrine Gland Neoplasms [C04.588.322]
Pancreatic Neoplasms [C04.588.322.475]
Digestive System Diseases [C06]
Digestive System Neoplasms [C06.301]
Pancreatic Neoplasms [C06.301.761]
Pancreatic Diseases [C06.689]
Pancreatic Neoplasms [C06.689.667]
Endocrine System Diseases [C19]
Endocrine Gland Neoplasms [C19.344]
Pancreatic Neoplasms [C19.344.421]

Below are MeSH descriptors whose meaning is more specific than "Pancreatic Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pancreatic Neoplasms" by people in this website by year, and whether "Pancreatic Neoplasms" was a major or minor topic of these publications.

Bar chart showing 175 publications over 23 distinct years, with a maximum of 14 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2004	3	2	5
2005	1	3	4
2006	7	1	8
2007	6	3	9
2008	3	0	3
2009	4	0	4
2010	5	0	5
2011	7	0	7
2012	5	0	5
2013	11	0	11
2014	12	0	12
2015	11	0	11
2016	9	2	11
2017	6	0	6
2018	5	0	5
2019	12	1	13
2020	11	0	11
2021	5	0	5
2022	7	0	7
2023	14	0	14
2024	11	0	11
2025	7	0	7

Below are the most recent publications written about "Pancreatic Neoplasms" by people in Profiles.

King DA, John KM, Tenner J, Nadella S, Zavadsky T, Carvino A, Khan S, Croocks R, McEvoy T, Beyer K, Mercieca R, Valente C, Bingham B, Cohn EG, Habowski AN, Tuveson DA, Barish MA, Carvajal RD. Computationally assisted patient finding for navigation to optimize pancreatic cancer care access. Oncologist. 2026 Mar 09; 31(4).

View in: PubMed
Ahmad M, Alvi SS, Ahsan H, Perez C, Massey A, Kashyap VK, Chauhan N, Anning E, Tripathi MK, Kim DJ, Sahoo N, Oraby T, Yallapu MM, Khan MM, Sebastian MM, Chauhan SC, Hafeez BB. Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth. Mol Cancer Ther. 2026 Feb 04; 25(2):257-271.

View in: PubMed
Tanji Y, Shimada S, Kato M, Akiyama Y, Hatano M, Tsukihara S, Igarashi Y, Kodera K, Okazaki K, Yasukawa K, Umemura K, Kamachi A, Nara A, Yamane M, Ishikawa Y, Mochizuki E, Mochida Y, Ikegami T, Ban D, Uchida S, Tanaka S. Cytokine mRNA-based therapy alleviates dendritic cell and T cell paucity to eliminate aggressive pancreatic cancer in preclinical mouse models. EBioMedicine. 2026 Mar; 125:106137.

View in: PubMed
Hoang T, Park H, Han Y, Jang JY, Shin A, Sohn H. A systematic review of economic evaluation in pancreatic cystic neoplasms. HPB (Oxford). 2026 Feb; 28(2):119-132.

View in: PubMed
Akin-Olugbemi O, Lucas D, Okoro J, Frimpong E, Bulusu R, Stone R, Flores-Rozas H, Agyare E, Jackson T, Ablordeppey S, Mohammed S, Vintilla B, Herremans K, Underwood PW, Delitto D, Thompson G, Riner AN, Trevino J, Hughes SJ, Han S, Yoon SL, Gobin C, Salhia B, Okunieff P, Fredenburg KM, Allen JM, Machona B, Reams RR, Wilkie DJ. Building Equitable Cancer Research Infrastructure: Successful Transfer of Patient-Derived Xenograft Technology to a Historically Black University. Cancer Control. 2025 Jan-Dec; 32:10732748251401261.

View in: PubMed
Barajas J, Yang Z, Agyare E, Zhu X, Yoon SJ, Han B. Matrix stiffness influences drug resistance to gemcitabine analog and AZD 1775 combination in PDAC organoids. PLoS One. 2025; 20(12):e0326550.

View in: PubMed
Umemura K, Akiyama Y, Shimada S, Hatano M, Kono A, Yasukawa K, Kamachi A, Igarashi Y, Tsukihara S, Tanji Y, Morimoto K, Nara A, Yamane M, Akahoshi K, Ono H, Shimizu A, Soejima Y, Tanabe M, Ban D, Tanaka S. PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer. Mol Cancer Res. 2025 Oct 02; 23(10):844-858.

View in: PubMed
Yoon SL, Grundmann O, Rogers S, Schlaeger JM, Han B, Agyare E, Wilkie DJ. Cachexia in Pancreatic Cancer: New Insights to Impact Quality of Life and Survival. Nutrients. 2025 Sep 25; 17(19).

View in: PubMed
Han S, Paik A, Acoba J, Wilkens LR, Le Marchand L, Huang BZ. Risk Factor Profiles and Elevated Incidence of Pancreatic Cancer in Native Hawaiians. Am J Gastroenterol. 2026 Jan 01; 121(1):274-276.

View in: PubMed
Jung HN, Huh JH, Roh E, Kim BJ, Lee M, Kim JK, Kim JH, Han B, Han KD, Kang JG, Lee SJ, Ihm SH. Risk of pancreatic cancer according to glycemic status in nonalcoholic fatty liver disease: a nationwide cohort study. Sci Rep. 2025 Jul 02; 15(1):23308.

View in: PubMed

People

Explore

Similar Concepts

Top Journals